The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity

被引：0
|
作者：
Prasad, Chandra Bhushan
Oo, Adrian
Qiu, Zhaojun
Li, Na
Singh, Deepika
Xin, Xiwen
Cho, Young-Jae
Li, Zaibo
Zhang, Xiaoli
Yan, Chunhong
Zheng, Qingfei
Shao, Jimin
Wang, Qi-En
Kim, Baek
Zhang, Junran
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 01期
关键词：
D O I：
10.1158/1538-7445.DNAREPAIR24-B024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B024
引用
收藏
页数：2
相关论文
共 16 条
  • [1] The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity
    Prasad, Chandra Bhushan
    Oo, Adrian
    Liu, Yujie
    Qiu, Zhaojun
    Zhong, Yaogang
    Li, Na
    Singh, Deepika
    Xin, Xiwen
    Cho, Young-Jae
    Li, Zaibo
    Zhang, Xiaoli
    Yan, Chunhong
    Zheng, Qingfei
    Wang, Qi-En
    Guo, Deliang
    Kim, Baek
    Zhang, Junran
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [2] Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine
    Goss, Kelli L.
    Koppenhafer, Stacia L.
    Harmoney, Kathryn M.
    Terry, William W.
    Gordon, David J.
    ONCOTARGET, 2017, 8 (50) : 87016 - 87032
  • [3] Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia INACTIVATION OF RIBONUCLEOTIDE REDUCTASE AND REDOX-MEDIATED CHECKPOINT CONTROL
    Muniyappa, Harish
    Song, Shiwei
    Mathews, Christopher K.
    Das, Kumuda C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (25) : 17069 - 17081
  • [4] CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation
    Liang, Min
    Zhao, Tiangang
    Ma, Linfeng
    Guo, Yingjie
    ONCOLOGY REPORTS, 2018, 39 (03) : 1322 - 1330
  • [5] Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer
    Bennett, Christina N.
    Tomlinson, Christine C.
    Michalowski, Aleksandra M.
    Chu, Isabel M.
    Luger, Dror
    Mittereder, Lara R.
    Aprelikova, Olga
    Shou, James
    Piwinica-Worms, Helen
    Caplen, Natasha J.
    Hollingshead, Melinda G.
    Green, Jeffrey E.
    BREAST CANCER RESEARCH, 2012, 14 (04)
  • [6] Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer
    Christina N Bennett
    Christine C Tomlinson
    Aleksandra M Michalowski
    Isabel M Chu
    Dror Luger
    Lara R Mittereder
    Olga Aprelikova
    James Shou
    Helen Piwinica-Worms
    Natasha J Caplen
    Melinda G Hollingshead
    Jeffrey E Green
    Breast Cancer Research, 14
  • [7] Redox Regulation of Actin by Thioredoxin-1 Is Mediated by the Interaction of the Proteins via Cysteine 62
    Wang, Xiaogang
    Ling, Shukuan
    Zhao, Dingsheng
    Sun, Qiao
    Li, Qi
    Wu, Feng
    Nie, Jielin
    Qu, Lina
    Wang, Bo
    Shen, Xun
    Bai, Yanqiang
    Li, Yingxian
    Li, Yinghui
    ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (05) : 565 - 573
  • [8] Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling
    Zhang, Yue
    Sun, Shibo
    Xu, Weiping
    Yang, Rui
    Yang, Yijia
    Guo, Jianli
    Ma, Kun
    Xu, Jianqiang
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 180 : 52 - 62
  • [9] RESVERATROL AMELIORATES RENAL ISCHEMIA-REPERFUSION INJURY VIA ACTIVATING GLYOXALASE 1 ACTIVITY AND THIOREDOXIN REDUCTASE/THIOREDOXIN SYSTEM
    Yeh, Wan Ju
    Pai, Man-Hui
    Tan, Hsiu-Yun
    Chen, Jiun-Rong
    Yang, Hsin-Yi
    ANNALS OF NUTRITION AND METABOLISM, 2017, 71 : 1187 - 1188
  • [10] Redox-mediated regulation of histone deacetylase4, a class II HDAC, by thioredoxin1 through interaction with DnaJb5, a heat shock protein 40
    Ago, Tetsuro
    Liu, Tong
    Li, Hong
    Molkentin, Jeffery
    Sadoshima, Junichi
    CIRCULATION, 2007, 116 (16) : 37 - 37
12